Publications
Whither Commercial Nanobiosensors?
The excitement surrounding the marriage of biosensors and nanotechnology is palpable even from a cursory examination of the scientific literature. Indeed, the word “nano” might be in danger of being overused and reduced to a cliché, although probably essential for publishing papers or securing research funding. The biosensor literature is littered with clever or catchy acronyms, birds being apparently favored (“CANARY”, “SPARROW”), quite apart from “electronic tongue,” “electronic nose,” and so on. Although biosensors have been around since glucose monitors were commercialized in the 1970s, the transition of laboratory research and innumerable research papers on biosensors into the world of commerce has lagged. There are several reasons for this phenomenon including the infamous “valley of death” afflicting entrepreneurs emerging from academic environment into the industrial world, where the rules for success can be radically different. In this context, musings on biosensors and especially nanobiosensors in an open access journal such as Journal of Biosensors and Bioelectronics is topical and appropriate especially since market surveys of biosensors are prohibitively expensive, sometimes running into thousands of dollars for a single copy. The contents and predictions of market share for biosensors in these reports also keep changing every time a report is published. Not only that, the market share projections for biosensors differs considerably amongst various reports. An editorial provides the opportunity to offer personal opinions and perhaps stimulate debate on a particular topic. In this sense, editorials are a departure from the rigor of a research paper. This editorial is no exception. With this preamble, it is worthwhile to stop and ponder the status of commercial biosensors and nanobiosensors.